Founded in 2005 and headquartered in Tokyo, Japan, SymBio Pharmaceuticals Ltd is a biopharmaceutical company that specializes in manufacturing and commercializing drugs for oncology, hematology, and pain management. The company's flagship product, Symbenda, is used to treat low-grade non-Hodgkin's lymphoma and chronic lymphatic leukemia in Singapore. SymBio Pharmaceuticals is committed to developing innovative therapies that improve the lives of patients suffering from serious illnesses.